| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 760 | $110 | $80K |
| J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 1,970 | $40 | $70.9K |
| J0897 | Injection, denosumab, 1 mg | 2,520 | $20 | $45.4K |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 37,500 | $1 | $37.5K |
| 99232 | The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making or… | 410 | $70 | $27.5K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 360 | $70 | $25.2K |
| J1454 | Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 70 | $340 | $21.8K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 150 | $120 | $17.9K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 100 | $150 | $14.9K |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 7,180 | $1 | $14.4K |